Development of combined vaccines for rabies and immunocontraception

Vaccine

Volumn 27, Issue 51, 2009, Pages 7202-7209

  Wu, Xianfu ^a   Franka, Richard ^a   Svoboda, Pavel ^b   Pohl, Jan ^b   Rupprecht, Charles E ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b DSR   (United States)

Author keywords

Contraception; Gonadotropin releasing hormone (GnRH); Rabies virus ERA; Rabies virus gene relocation; Reverse genetics

Indexed keywords

GLYCOPROTEIN; GONADORELIN; RABIES VACCINE;

ARTICLE; CELL CULTURE; CELL INCLUSION; CYTOPLASM; GENE EXPRESSION; GENE SEQUENCE; IMMUNIZATION; IMMUNOCONTRACEPTION; IMMUNOGENICITY; IN VITRO STUDY; PRIORITY JOURNAL; RABIES; RABIES VIRUS; VIRUS RECOMBINANT;

ANIMALS; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; CONTRACEPTION, IMMUNOLOGIC; FEMALE; GLYCOPROTEINS; GONADOTROPIN-RELEASING HORMONE; MICE; MICE, INBRED ICR; MUTAGENESIS, INSERTIONAL; RABIES; RABIES VACCINES; RABIES VIRUS; RNA, VIRAL; VACCINES, COMBINED; VACCINES, CONTRACEPTIVE; VIRAL ENVELOPE PROTEINS;

EID: 71849084816     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.09.025     Document Type: Article

References (44)

1. Peter S., Zhang Y., Luo J., Lundeberg J., and Leitner T. Genetic evidence for an East Asian origin of domestic dogs. Science 298 November (22) (2002) 1610-1613
2. Clutton-Brok J. In: Serpell J. (Ed). The domestic dog: its evolution, behavior and interactions with people (1995), Cambridge University Press, Cambridge, UK 7-20
3. Davis S.J.M., and Valla F.R. Evidence for domestication of the dog 12,000 years ago in the Natufian of Israel. Nature 276 December (7) (1978) 608-610
4. Baer G.M. Rabies-a historical perspective. Infect Agents Dis 3 August (4) (1994) 168-180
5. Winkler W.G. Fox rabies. In: Baer G.M. (Ed). The natural history of rabies. 1st ed. (1975), Academic Press, New York 3-22
6. Cleaveland S., Kaare M., and Knobel M.K. Canine vaccination-providing broader benefits for disease control. Vet Microbiol 117 October (5) (2006) 43-50
7. van der Z.A., Noordegraaf C.V., van den B.H., Gielen J., Bergmans H., Hoekstra W., et al. P-fimbriae of Escherichia coli as carriers for gonadotropin releasing hormone: development of a recombinant contraceptive vaccine. Vaccine 13 (1995) 753-758
8. Levy J.K., Miller L.A., Crawford P.C., Ritchey J.W., Ross M.K., and Fagerstone K.A. GnRH immunocontraception of male cats. Theriogenology 62 September (15) (2004) 1116-1130
9. Conforti V.A., Avila de D.M., Cummings N.S., Wells K.J., Ülker H., and Reeves J.J. The effectiveness of a CpG motif-based adjuvant (CpG ODN 2006) for LHRH immunization. Vaccine 25 August (29) (2007) 6537-6543
10. Conforti V.A., Avila de D.M., Cummings N.S., Zanella R., Wells K.J., Ülker H., et al. CpG motif-based adjuvant as a replacement for Freund's complete adjuvant in a recombinant LHRH vaccine. Vaccine 26 February (13) (2008) 907-913
11. Munson L. Contraception in fields. Theriogenology 66 July (1) (2006) 126-134
12. Kutzler M., and Wood A. Non-surgical methods of contraception and sterilization. Theriogenology 66 August (1) (2006) 514-525
13. Khan M.A.H., Ferro V.A., Koyama S., Kinugasa Y., Song M., Ogita K., et al. Immunization of male mice with a plasmid DNA vaccine encoding gonadotrophin releasing hormone (GnRH-I) and T-helper epitopes suppressing fertility in vivo. Vaccine 25 May (4) (2007) 3544-3553
14. Walker J., Ghosh S., Pagnon J., Colantoni C., Newbold A., Zeng W., et al. Totally synthetic peptide-based immunocontraceptive vaccines show activity in dogs of different breeds. Vaccine 25 October (10) (2007) 7111-7119
15. Claus R.C., Rotter S., and Rueckert C. Individual return to Leydig cell function after GnRH-immunization of boars. Vaccine 26 August (18) (2008) 4571-4578
16. Zhang Y., Rozell T.G., Avila de D.M., Bertrand K.P., and Reeves J.J. Development of recombinant ovalbumin-luteinizing hormone releasing hormone as a potential sterilization vaccine. Vaccine 17 April (23) (1999) 2185-2191
17. Jung M.J., Moon Y.C., Cho I.H., Yeh J.Y., Kim S.E., Chang W.S., et al. Induction of castration by immunization of male dogs with recombinant gonadotropin-releasing hormone (GnRH)-canine distemper virus (CDV) T helper cell epitope p35. J Vet Sci 6 March (1) (2005) 21-22
18. Zeng W., Gauci S., Ghosh S., Walker J., and Jackson D.C. Characterization of the antibody response to a totally synthetic immunocontraceptive peptide vaccine based on LHRH. Vaccine 23 August (15) (2005) 4427-4435
19. Wu X., and Rupprecht C.E. Glycoprotein gene relocation in rabies virus. Virus Res 131 January (1) (2008) 95-99
20. Wu X., Franka R., Velasco-Villa A., and Rupprecht C.E. Are all lyssavirus genes equal for phylogenetic analyses?. Virus Res 129 November (2) (2007) 91-103
21. Wu X., Gong X., Foley H.D., Schnell M.J., and Fu Z.F. Both viral transcription and replication are reduced when the rabies virus nucleoprotein is not phosphorylated. J Virol 76 May (9) (2002) 4153-4161
22. Thomas J.B., Ricker A.S., Baer G.M., and Sikes R.K. Purification of fixed rabies virus. Virology 25 February (1965) 271-275
23. Sokol F., Kuwert E., Wiktor T.J., Hummeler K., and Koprowski H. Purification of rabies virus grown in tissue culture. J Virol 2 August (8) (1968) 836-849
24. Coulon P., Rollin P.E., and Flamand A. Molecular basis of rabies virus virulence. II. Identification of a site on the CVS glycoprotein associated with virulence. J Gen Virol 64 March (3) (1983) 693-696
25. Seif I., Coulon P., Rollin P.R., and Flamand A. Rabies virulence: effect on pathogenicity and sequence characterization of rabies virus mutations affecting antigenic site III of the glycoprotein. J Virol 53 March (3) (1985) 926-934
26. Prehaud C., Coulon P., LaFay F., Thiers C., and Flammand A. Antigenic site II of the rabies virus glycoprotein: structure and role in viral virulence. J Virol 62 January (1) (1988) 1-7
27. Wandeler A.I., Budde A., Capt S., Kappeler A., and Matter H. Rabies ecology and dog rabies control. Rev Infect Dis Suppl. 4 November-December (10) (1988) S684-S688
28. Meslin F.X., Fishbein D.B., and Matter H. Rationale and prospects for rabies elimination in developing countries. Curr Top Microbiol Immunol 187 (1994) 1-26
29. Takayama N. Rabies control in Japan. Jpn J Infect Dis 53 June (3) (2000) 93-97
30. World Health Organization technical report series no. 82. Expert Committee on Rabies, 2nd report; April 1954. p. 1-27.
31. Zinsstag J., Schelling E., Roth F., Bonfoh B., Savigny D., and Tanner B. Human benefits of animal interventions for zoonosis control. Emerg Infect Dis 13 April (4) (2007) 527-531
32. Reece J.F., and Chawla S.K. Control of rabies in Jaipur, India, by the sterilization and vaccination of neighborhood dogs. Vet Rec 159 September (16) (2006) 379-383
33. Tepsumethanon V., Wilde H., and Hemachudha T. Intratesticular injection of a balanced zinc solution for permanent sterilization of dogs. J Med Assoc Thai 88 May (5) (2005) 686-689
34. Levy J.K., Crawford P.C., Appel L.D., and Clifford E.L. Comparison of intratesticular injection of zinc gluconate versus surgical castration to sterilize male dogs. Am J Vet Res 69 January (1) (2008) 140-143
35. Boyle D.B. Disease and fertility control in wildlife and feral animal populations: options for vaccine delivery using vectors. Reprod Fertil Dev 6 3 (1994) 393-400
36. Miller L.A., Gionfriddo J.P., Fagerstone K.A., and Rhyan J.C. The single-shot GnRH immunocontraceptive vaccine (GonaCon) in white-tailed deer: comparison of several GnRH preparations. Am J Reprod Immunol 60 September (3) (2008) 214-223
37. Killian G., Kreeger T.J., Rhyan J., Fagerstone K., and Miller L.A. Observations on the use of GonaCon in captive female elk (Cervus elaphus). J Wildl Dis 45 January (1) (2009) 184-188
38. Lafon M. Rabies virus superantigen. Res Immunol 144 March-April (3) (1993) 209-213
39. Lafon M., and Galelli A. Superantigen related to rabies. Springer Semin Immunopathol 17 4 (1996) 307-318
40. Astoul E., Lafage M., and Lafon M. Rabies superantigen as a Vbeta T-dependent adjuvant. J Exp Med 183 April (1) (1996) 1623-1631
41. Whitt M.A., Buonocore L., Prehaud C., and Rose J.K. Membrane fusion activity, oligomerization, and assembly of the rabies virus glycoprotein. Virology 181 December (2) (1991) 681-688
42. Gaudin Y., Ruigrok R., Knossow M., and Flamand A. Rabies virus glycoprotein is a trimer. Virology 187 April (2) (1992) 627-632
43. Cox J.H., Dietzschold B., and Schneider L.G. Rabies virus glycoprotein II. Biological and serological characterization. Infect Immun 16 June (3) (1977) 754-759
44. Dietzschold B., Wunner W.H., Wiktor T.K., Lopes A.D., Lafon M., Smith C.L., et al. Characterization of an antigenic determinant of the glycoprotein that correlates with pathogenicity of rabies virus. Proc Natl Acad Sci USA 80 January (1) (1983) 70-74